JUBLPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Jubilant Pharmova's Board has approved the re-appointment of Mr. Priyavrat Bhartia as Managing Director and Mr. Arjun Shanker Bhartia as Joint Managing Director for another 3 years starting June 1, 2026. Both appointments are subject to shareholder approval at the upcoming general meeting. Both individuals are sons of the company's senior leadership - Priyavrat is son of Chairman Shyam Sunder Bhartia, and Arjun is son of Co-Chairman Hari Shanker Bhartia. Both have been in their current roles since June 2023 and on the board since May 2017, bringing 29 and several years of industry experience respectively.
This represents continuity in leadership for Jubilant Pharmova with the Bhartia family continuing to hold key executive positions. The re-appointments are internal promotions rather than external hires, suggesting stability in the company's strategic direction.